It is a trading private limited company based in New Delhi, Delhi, India, established in 2011.
2011 | New Delhi, Delhi, India | Struck OffAurogen Pharmaceuticals Private Limited, a struck off private limited company, was established on 28 March 2011 in New Delhi, Delhi, India. Engaging in wholesale within the trading sector, it holds CIN: U51909DL2011PTC216651. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Ankur Singh Kachhawaha (Director), Manish Maurya (Director), Shiv Prakash Pandey (Director). Past directors included Ankur Singh Kachhawaha, Manish Maurya, Diwakar Pratap Singh. Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at U-87, 3Rd Floor, Near Lakshmi Nagar Metro Station Vikas Marg, Shakarpur, New Delhi, Delhi, 110092.
U51909DL2011PTC216651
216651
28 March 2011
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Aurogen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankur Singh Kachhawaha | Director | 24 Jun 2011 | Current |
| Manish Maurya | Director | 31 May 2012 | Current |
| Shiv Prakash Pandey | Director | 28 Mar 2011 | Current |
| Diwakar Pratap Singh | Director | 24 Jun 2011 | Current |
| Rajneesh Kumar Singh | Director | 28 Mar 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Aurogen Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Aurogen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aurogen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aurogen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurogen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aurogen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was documented.
Aurogen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was recorded as a recent event.
Manish Maurya was appointed as a Director was appointed as a Director on 31 May 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.
Progress on Ankur Singh Kachhawaha was appointed as a Director was appointed as a Director on 24 Jun 2011 & has been associated with this company since 14 years 6 months . was documented.
Progress on Diwakar Pratap Singh was appointed as a Director was appointed as a Director on 24 Jun 2011 & has been associated with this company since 14 years 6 months . was documented.
Progress on Shiv Prakash Pandey was appointed as a Director was appointed as a Director on 28 Mar 2011 & has been associated with this company since 14 years 9 months . was documented.
The CIN of Aurogen Pharmaceuticals Private Limited is U51909DL2011PTC216651.
Aurogen Pharmaceuticals Private Limited is headquartered at U-87, 3Rd Floor, Near Lakshmi Nagar Metro Station Vikas Marg, Shakarpur, New Delhi, Delhi, 110092.
Aurogen Pharmaceuticals Private Limited was incorporated on 28 March 2011.
The current directors of Aurogen Pharmaceuticals Private Limited are
The primary industry of Aurogen Pharmaceuticals Private Limited is Trading.
Aurogen Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aurogen Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX